We further inferred the transcriptional activity of SREBF2 in the TP53 mutation group and DCIS based on RNA‐seq data using the master regulator inference algorithm (MARINa) compiled in the R package “viper”. Here, SREBF2 is linked to ductal breast carcinoma in situ.